article thumbnail

The rising impact of biomarkers in early clinical development

Drug Target Review

2 This progress has implications for diagnosis, therapeutic efficacy, and potentially establishing clinically relevant endpoints. 2001) Biomarkers Definitions Working Group Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clinical Pharmacology and Therapeutics. Bagyinszky E, et al. 21(10):3517.

article thumbnail

Keys to Success in Vaccine Development for Special Populations

PPD

From study participants’ consent, to minimizing the patient and caregiver burden, to planning for different needs at different stages of the pediatric immune system, there are many factors to consider when conducting clinical research with this specific population.

Vaccine 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Chemistry Clicked: Two NIH-Supported Researchers Win 2022 Nobel Prize in Chemistry

NIH Director's Blog: Drug Development

Barry Sharpless, Scripps Research, La Jolla, CA, October 5, 2022 marked the second time that he’s received an early-morning congratulatory call from The Royal Swedish Academy of Sciences. 2001, 40 (11), 2004–2021 [2] A stepwise huisgen cycloaddition process: Copper(I)-catalyzed regioselective “Llgation” of azides and terminal alkynes.

article thumbnail

Pivotal phase III clinical trial IND submission of the original innovative anticancer drug Chiauranib for the treatment of small cell lung cancer was accepted by the Center of Drug Evaluation of the NMPA.

The Pharma Data

SH ) was founded in Shenzhen on 2001, specializing in the research and development of novel small molecule drugs. At present, Chiauranib has globally applied for more than 40 patents of invention. About CHIPSCREEN BIOSCIENCES. Shenzhen Chipscreen Biosciences Co., Chipscreen Biosciences, Stock Symbol: 688321.

article thumbnail

Four Pain Models Altasciences Uses to Assess Treatments During Clinical Trials

Alta Sciences

Altasciences’ experienced clinical researchers can accommodate and advise you on your pain management and treatment contributions, the needs of your therapeutic studies, how to best utilize various pain models, and evaluate and assess the efficacy of your treatment. billion people that suffer from chronic pain, globally , (51.6

article thumbnail

Human neuronal cells: possibilities in drug safety testing

Drug Target Review

She completed a PhD at Durham University which focused on investigating the mechanisms of cardiotoxicity of cancer therapies using clinically relevant in vitro human models of cardiac physiology paired with novel methodologies to evaluate structural and functional toxicities. 2001 Sep;24(9):517–26. Adv Drug Deliv Rev. Trends Neurosci.

Drugs 111
article thumbnail

Navigating the Complex Regulatory CRO Landscape for Oncology Trials in the European Union

Conversations in Drug Development Trends

Regulatory Harmonization of Clinical Trials in the EU The EU-CTR repealed the Clinical Trial Directive 2001/20/EC (CTD) and national implementing legislation in the EU Member States on 31 January 2022.

Trials 52